Comparative efficacy of first-line natalizumab versus IFNb or glatiramer acetate in relapsing MS

Date

2015

Author

Spelman, T.
Kalincik, T.
Jokubaitis, V.
Zhang, A.
Pellegrini, F.
Wiendl, H.
Lechner-Scott, J.

Metadata

Show full item record

Abstract

…

Source

Multiple Sclerosis Journal

Volume

21

URI

https://hdl.handle.net/20.500.12712/14090

Collections